The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic Pneumonia

Phase 4, Randomized Study of Three Months-prednisolone Therapy in the Treatment of Chronic Eosinophilic Pneumonia

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00632554

Enrollment

Registered

2008-03-10

Start date

2008-06-30

Completion date

2010-03-31

Last updated

2014-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Disease, Eosinophilic Pneumonia

Brief summary

A comparison of 3 months-prednisolone administration with 6 months-prednisolone therapy in the treatment of chronic eosinophilic pneumonia. Three months-prednisolone administration may be as effective as 6 months-therapy.

Interventions

DRUGprednisolone 0.5 mg/kg/day for three months

period of treatment

DRUGprednisolone 0.5 mg/kg/day for six months

period of therapy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

16 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Biopsy-proven chronic eosinophilic pneumonia

Exclusion criteria

* Patients who received oral glucocorticosteroid (more than 10 mg) * Immunosuppressive drug

Design outcomes

Primary

Measure	Time frame
Efficacy of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia	Three years

Secondary

Measure	Time frame
Safety of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia	Three years

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026